(+49) 176 69639585
(+49) 176 69639585
Strong pharmaceutical production with export capabilities.
Opportunities:
Contract manufacturing
Clinical research cooperation
Supplier identification
Opportunities for Germany & the European Union
Argentina has one of Latin America’s most advanced and export-oriented pharmaceutical sectors. With over a century of industrial development, strong regulatory frameworks, and a highly skilled scientific workforce, the country has established itself as a regional leader in:
Pharmaceutical manufacturing (generics, branded generics, injectables, biosimilars)
Biotech innovation (vaccines, monoclonal antibodies, diagnostics)
Active pharmaceutical ingredient (API) production
Clinical research and medical technology
Public–private healthcare research partnerships
The sector benefits from a sophisticated network of national pharmaceutical laboratories, R&D centres, medical universities, and a well-regulated environment aligned with international standards such as GMP, GLP, GCP, and WHO norms.
Argentina maintains a diversified and export-ready manufacturing base that includes:
Solid oral forms: tablets, capsules, controlled-release formulations
Injectables: sterile liquids, lyophilised products
Biopharmaceuticals: biosimilars, vaccines, plasma derivatives
OTC & Prescription lines: dermatology, oncology, cardiology, metabolic diseases
API production: especially antibiotics, hormones, analgesics, and specialty APIs
Many facilities are certified for international compliance, enabling export to Latin America, the EU, and other regulated markets.
Argentina’s biotechnology industry is one of the strongest in the region, supported by:
Research universities and national science institutions
Local biotech firms developing vaccines, recombinant proteins and diagnostics
Government-supported innovation programs
Human resource excellence in biology, chemistry, medical engineering, and AI for health
The country is emerging as an attractive destination for clinical studies, medical data services, and R&D cooperation.
The pharma sector is supported by:
GDP/GMP-certified cold-chain warehouses
Temperature-controlled distribution centres
Dedicated pharma logistics providers
Digital documentation and traceability systems
This enables safe export of sensitive goods such as biologics, vaccines, and specialty medicines.
European pharma and biotech companies can benefit from Argentina’s:
Competitive manufacturing costs
GMP-certified production facilities
Skilled chemists, pharmacists, and biotechnologists
Flexibility in batch sizes and technical transfers
Contract manufacturing opportunities include:
APIs & intermediates
Solid and liquid finished dosage forms
Biopharmaceuticals & biosimilars
Secondary packaging & labeling for regional distribution
Argentina can serve as both a regional production base and a cost-efficient extension of EU manufacturing pipelines.
Argentina has become a reputable market for international clinical trials due to:
High-quality medical institutions
Strong patient recruitment rates
Skilled clinical investigators
Alignment with ICH-GCP standards
Reliable regulatory oversight
Opportunities for German/EU sponsors include:
Phase I–IV clinical trials
Bioequivalence studies
Real-world evidence & epidemiological research
Collaborative research with universities and biotech hubs
This can significantly reduce development timelines and R&D costs.
European procurement teams increasingly look to Argentina for:
Pharmaceutical ingredients
Formulated products
Biotech reagents & lab consumables
Medical devices
Diagnostics & point-of-care technologies
The country offers a structured network of reliable suppliers with capabilities in:
Custom synthesis
Specialty APIs
Niche biotech products
Hospital-use medicines
R&D materials
Argentina’s supplier ecosystem is ideal for dual sourcing, risk diversification, and cost optimization for EU companies.
Highly regulated pharma environment aligned with international norms
Scientific talent pool, especially in chemistry, biology, clinical pharmacology & biotechnology
Modern manufacturing facilities capable of producing complex formulations
Cost-attractive production, improving margins for EU companies
Strong B2B cooperation culture, with many companies already exporting globally
Growing biotech cluster, well-positioned for long-term partnerships
Reliable cold-chain logistics enabling sensitive exports
Political focus on healthcare innovation, supporting foreign cooperation
Contract Manufacturing (Branded generics, biosimilars, injectables)
Technology Transfers (process optimization, quality systems, automation)
Joint R&D (vaccines, biologics, AI in health)
Clinical Trials & Medical Data Services
Sourcing & Supplier Audits
Biotech innovation partnerships
Pharma logistics solutions
